Differential effectiveness of pharmacological strategies to reveal dormant pulmonary vein conduction: A clinical-experimental correlation

Heart Rhythm

Volumn 8, Issue 9, 2011, Pages 1426-1433

  Datino, Tomas ^a,b   Macle, Laurent ^a   Chartier, Denis ^a   Comtois, Philippe ^a   Khairy, Paul ^a   Guerra, Peter G ^a   Fernandez Aviles, Francisco ^b   Nattel, Stanley ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Ablation; Adenosine; Arrhythmia; Atrium; Electrophysiology; Isoproterenol

Indexed keywords

ADENOSINE; ISOPRENALINE; ANTIARRHYTHMIC AGENT; CARDIOTONIC AGENT; DIAGNOSTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DORMANT PULMONARY VEIN CONDUCTION; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERPOLARIZATION; IN VITRO STUDY; MALE; MEMBRANE ELECTROPHYSIOLOGY; MEMBRANE POTENTIAL; MEMBRANE STEADY POTENTIAL; PRIORITY JOURNAL; PULMONARY VEIN ISOLATION; RADIOFREQUENCY ABLATION; THERAPY EFFECT; ANIMAL; CATHETER ABLATION; DOG; DRUG ADMINISTRATION; DRUG EFFECT; HEART MUSCLE CONDUCTION SYSTEM; MIDDLE AGED; PATHOPHYSIOLOGY; PULMONARY VEIN;

ADENOSINE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIOTONIC AGENTS; CATHETER ABLATION; DOGS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; ISOPROTERENOL; MALE; MIDDLE AGED; PULMONARY VEINS;

EID: 84855472900     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2011.04.011     Document Type: Article

References (27)

1. J aïs P, Cauchemez B, Macle L, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation. Circulation 2008;118:2498 -2505.
2. Pappone C, Augello G, Sala S, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation. J Am Coll Cardiol 2006;48:2340 -2347.
3. Wilber DJ, Pappone C, Neuzil P, et al, and the ThermoCool AF Trial Investigators. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: A randomized controlled trial. JAMA 2010;303:333-340.
4. Cappato R, Negroni S, Pecora D, et al. Prospective assessment of late conduction recurrence across radiofrequency lesions producing electrical disconnection at the pulmonary vein ostium in patients with atrial fibrillation. Circulation 2003;108:1599 -1604.
5. Nanthakumar K, Plumb VJ, Epstein AE, Veenhuyzen GD, Link D, Kay GN. Resumption of electrical conduction in previously isolated pulmonary veins: Rationale for a different strategy? Circulation 2004;109:1226 -1229.
6. A rentz T, Macle L, Kalusche D, et al. "Dormant" pulmonary vein conduction revealed by adenosine after ostial radiofrequency catheter ablation. J Cardiovasc Electrophysiol 2004;15:1041-1047.
7. Tritto M, De Ponti R, Salerno-Uriarte JA, et al. A denosine restores atrio-venous conduction after apparently successful ostial isolation of the pulmonary veins. Eur Heart J 2004;25:2155-2163.
8. Sauer WH, McKernan ML, Lin D, Gerstenfeld EP, Callans DJ, Marchlinski F. Clinical predictors and outcomes associated with acute return of pulmonary vein conduction during pulmonary vein isolation for treatment of atrial fibrillation. Heart Rhythm 2006;3:1024 -1028.
9. Hachiya H, Hirao K, Takahashi A, et al. Clinical implications of reconnection between the left atrium and isolated pulmonary veins provoked by adenosine triphosphate after extensive encircling pulmonary vein isolation. J Cardiovasc Electrophysiol 2007;18:392-398.
10. Matsuo S, Yamane T, Date T, et al. Reduction of AF recurrence after pulmonary vein isolation by eliminating ATP-induced transient venous re-conduction. J Cardiovasc Electrophysiol 2007;18:704 -708.
11. Matsuo S, Yamane T, Date T, et al. Comparison of the clinical outcome after pulmonary vein isolation based on the appearance of adenosine induced dormant pulmonary vein conduction. Am Heart J 2010;160:337-345.
12. Fuster V, Rydén LE, Cannom DS, et al, and the Task Force on Practice Guidelines, American College of Cardiology/American Heart Association; Committee for Practice Guidelines, European Society of Cardiology; European Heart Rhythm Association; Heart Rhythm Society. A CC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 2006;27:1979 -2030.
13. Kneller J, Ramirez RJ, Chartier D, Courtemanche M, Nattel S. Time dependent transients in an ionically based mathematical model of the canine atrial action potential. Am J Physiol Heart Circ Physiol 2002;282:H1437-1451.
14. Datino T, Macle L, Qi XY, et al. Mechanisms by which adenosine restores conduction in dormant canine pulmonary veins. Circulation 2010;121:963- 972.
15. Callans DJ, Gerstenfeld EP, Dixit S, et al. Efficacy of repeat pulmonary vein isolation procedures in patients with recurrent atrial fibrillation. J Cardiovasc Electrophysiol 2004;15:1050 -1055.
16. Oral H, Knight BP, Tada H, et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 2002;105:1077-1081.
17. Cheema A, Dong J, Dalal D, et al. Incidence and time course of early recovery of pulmonary vein conduction after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2007;18:387-391.
18. Ninomiya Y, Iriki Y, Ishida S, et al. Usefulness of the adenosine triphosphate with a sufficient observation period for detecting reconduction after pulmonary vein isolation. PACE 2009;32:1307-1312.
19. Rajappan K, Kistler PM, Earley MJ, et al. A cute and chronic pulmonary vein reconnection after atrial fibrillation ablation: A prospective characterization of anatomical sites. PACE 2008;31:1598 -1605.
20. Wang XH, Liu X, Sun YM, et al. Early identification and treatment of PV re-connections: Role of observation time and impact on clinical results of atrial fibrillation ablation. Europace 2007;9:481- 486.
21. Froldi G, Belardinelli L. Species-dependent effects of adenosine on heart rate and atrioventricular nodal conduction: Mechanism and physiological implications. Circ Res 1990;67:960 -978.
22. Zicha S, Tsuji Y, Shiroshita-Takeshita A, Nattel S. Beta-blockers as antiarrhythmic agents. In: Kass RS, Clancy CC, eds. Handbook of experimental pharmacology- basis and treatment of cardiac arrhythmias. Vol. 171. Heidelberg: Springer Publishing, 235-266.
23. Wang TM, Luk HN, Sheu JR, Wu HP, Chiang CE. Inducibility of abnormal automaticity and triggered activity in myocardial sleeves of canine pulmonary veins. Int J Cardiol 2005;104:59-66.
24. Doisne N, Maupoil V, Cosnay P, Findlay I. Catecholaminergic automatic activity in the rat pulmonary vein: Electrophysiological differences between cardiac muscle in the left atrium and pulmonary vein. Am J Physiol (Heart Circ Physiol) 2009;297:H102-108.
25. Han W, Wang Z, Nattel S. Slow delayed rectifier current and repolarization in canine cardiac Purkinje cells. Am J Physiol (Heart Circ Physiol) 2001;280: H1075-1080.
26. A shar MS, Pennington J, Callans DJ, Marchlinski FE. Localization of arrhythmogenic triggers of atrial fibrillation. J Cardiovasc Electrophysiol 2000;11: 1300-1305.
27. Eitel C, Hindricks G, Sommer P, et al. Circumferential pulmonary vein isolation and linear left atrial ablation as a single-catheter technique to achieve bidirectional conduction block: The pace-and-ablate approach. Heart Rhythm 2010;7: 165-166.